Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

2.75
Delayed Data
As of Aug 18
 +0.04 / +1.48%
Today’s Change
1.93
Today|||52-Week Range
5.70
-13.33%
Year-to-Date
Institutional investors purchased a net $12.1 thousand shares of XTLB during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 1.11% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders0.66%
Other institutional0.45%
Individual stakeholders--

Largest Quarterly Institutional
Transactions

Latest Institutional Activity

6/30/2017UBS SECURITIES LLC  Bought 11.0 Thousand shares of X T L Biopharmaceuticals ...
6/30/2017MORGAN STANLEY & CO. LLC  Bought 1.1 Thousand shares of X T L Biopharmaceuticals ...

Top 10 Owners of X T L Biopharmaceuticals Ltd

StockholderStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Invesco Asset Management Ltd.0.51%25,96188,26700.00%
UBS Securities LLC0.32%16,30955,451+10,989+206.56%
IBI Mutual Funds Management (1978...0.16%8,06027,40400.00%
Morgan Stanley & Co. LLC0.13%6,66022,644+1,100+19.78%

Top 10 Mutual Funds Holding X T L Biopharmaceuticals Ltd

Mutual fundStakeShares
owned
Total value ($)Shares
bought / sold
Total
change
Perpetual Income & Growth Investm...0.38%19,60366,65000.00%
I.B.I. Foreign Equity Liable0.16%8,06027,40400.00%
Keystone Investment Trust Plc0.10%5,16817,571+5,168--
Invesco Perpetual UK 2 Invt. Seri...0.02%1,1914,049-1-0.08%